Case Reports
doi: 10.1136/jnnp.70.3.417.
Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach
- PMID: 11248905
- PMCID: PMC1737230
- DOI: 10.1136/jnnp.70.3.417
Item in Clipboard
Case Reports
Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach
J Neurol Neurosurg Psychiatry.
2001 Mar.
No abstract available
Comment on
-
Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):121-3. doi: 10.1136/jnnp.69.1.121. J Neurol Neurosurg Psychiatry. 2000. PMID: 10864618 Free PMC article.
Similar articles
-
Safety and administration of treatment with botulinum neurotoxin for sialorrhoea in ALS patients: review of the literature and a proposal for tailored treatment.Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):516-20. doi: 10.3109/21678421.2013.830312. Epub 2013 Aug 28. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23984863 Review.
-
Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):121-3. doi: 10.1136/jnnp.69.1.121. J Neurol Neurosurg Psychiatry. 2000. PMID: 10864618 Free PMC article.
-
Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.J Neurol Sci. 2001 Sep 15;190(1-2):95-7. doi: 10.1016/s0022-510x(01)00565-2. J Neurol Sci. 2001. PMID: 11574113
-
Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.Muscle Nerve. 2006 Aug;34(2):235-7. doi: 10.1002/mus.20545. Muscle Nerve. 2006. PMID: 16583370 Clinical Trial.
-
Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.Am J Phys Med Rehabil. 2008 Apr;87(4):321-4. doi: 10.1097/PHM.0b013e318164a931. Am J Phys Med Rehabil. 2008. PMID: 18303472 Review.
Cited by
-
Clinical diagnosis and management of amyotrophic lateral sclerosis.Nat Rev Neurol. 2011 Oct 11;7(11):639-49. doi: 10.1038/nrneurol.2011.153. Nat Rev Neurol. 2011. PMID: 21989247 Review.
-
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.Cochrane Database Syst Rev. 2022 May 20;5(5):CD006981. doi: 10.1002/14651858.CD006981.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593746 Free PMC article.
-
Therapy of Sialorrhea with Botulinum Neurotoxin.Neurol Ther. 2019 Dec;8(2):273-288. doi: 10.1007/s40120-019-00155-6. Epub 2019 Sep 21. Neurol Ther. 2019. PMID: 31542879 Free PMC article. Review.
-
Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children-update and practice recommendations.Front Neurol. 2023 Dec 13;14:1275807. doi: 10.3389/fneur.2023.1275807. eCollection 2023. Front Neurol. 2023. PMID: 38162447 Free PMC article. Review.
-
Sialorrhea in patients with ALS: current treatment options.Degener Neurol Neuromuscul Dis. 2019 Mar 20;9:19-26. doi: 10.2147/DNND.S168353. eCollection 2019. Degener Neurol Neuromuscul Dis. 2019. PMID: 31118868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
